🟢 MDxHealth is trading 6% up — no company-specific catalyst identified

MDxHealth is trading at $0.19, up +6.11%, with no new company-specific announcement identified to explain the October 20 move.

• The October 15 preliminary Q3 revenue announcement and suspended full-year guidance are earlier context, not a confirmed cause of the rebound.
• Healthcare-sector context reports XLV up 2.12%, while broader U.S. indexes also finished higher. No volume information was provided.